Observational studyEye (London, England)2017

Identification of time point to best define 'sub-optimal response' following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data.

I Chatziralli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.